Glaxosmithkline Share News (GSK)

GSK gets an approval in Japan, a recommendation in Europe

(Sharecast News) - GSK announced two significant advancements on Monday, with the approval of an updated indication for Shingrix in Japan, as well as a positive opinion from the European Medicines Agency for daprodustat.

GSK soothes investors by settling first Zantac cancer lawsuit due for US trial

GSK shares best performer on London's stock market

*

DIRECTOR DEALINGS: GSK CFO buys shares worth GBP321,500

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and not separately reported by Alliance News:

European shares post worst week in three months, Siemens Energy slumps

Siemens Energy weighs on German stocks

*

London stocks log sharp weekly declines as rate hike pressures mount

UK shoppers boost spending again in May

*

LONDON MARKET CLOSE: Stocks end in the red as recession fears mount

(Alliance News) - Stocks in London closed lower on Friday as weak economic data and the prospect of global interests staying higher for longer put investors in a firmly risk-off mood.

The best-is-yet-to-come narrative fades

Euro zone business growth stalls in June -flash PMI

*

LONDON MARKET MIDDAY: Housebuilders bear brunt of rate hike worries

(Alliance News) - Stock prices in London were lower heading into Friday afternoon, as a poor week for equities continued, with investors fretting over the prospect of central banks keeping interest rates higher for longer.

‘Dictator? That’S Absurd’: a guide for investors navigating U.S.-China tensions

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

‘DICTATOR? THAT’S ABSURD’: A GUIDE FOR INVESTORS NAVIGATING U.S.-CHINA TENSIONS (0915 GMT)

PMIs in focus as healthcare staves off deeper losses

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

PMIS IN FOCUS, HEALTHCARE STAVES OFF DEEPER LOSSES (0840 GMT)

LONDON MARKET OPEN: Stocks down after BoE; GSK up on Zantac settlement

(Alliance News) - Stock prices in London opened lower on Friday, as rising interest rates weighed on housebuilding stocks in the FTSE 100.

GSK reaches settlement in Goetz Zantac lawsuit

(Sharecast News) - GSK updated the market on the litigation regarding the now-discontinued heartburn drug ranitidine, or 'Zantac', on Friday.

TOP NEWS: GSK reaches settlement in California Zantac lawsuit

(Alliance News) - GSK PLC on Friday said a Zantac trial set to begin next month in California has been dismissed after it reached a confidential settlement.

Europe open: Stocks on the defensive after weak PMIs, euro awalloped

(Sharecast News) - Stocks on the Continent were trading on the back foot following the release of much weaker than expected readings for euro area factory and services activity.

LONDON BRIEFING: GSK settles Zantac litigation in California

(Alliance News) - Stocks in London are set to open in the red on Friday, as risk sentiment across the globe is damped by hawkish central banks.